Alberto Auricchio

Alberto Auricchio has extensive work experience in the field of medical genetics and gene therapy. Alberto is the Founder and Chief Scientific Officer of AAVantgarde Bio, a company focused on innovative therapeutics. Additionally, they serve as Vice President of the European Society of Gene and Cell Therapy.

Alberto has held various academic positions at the University of Naples Federico II, including Faculty Lecturer in Medical Genetics at the SSM-Scuola Superiore Meridionale, Full Professor of Medical Genetics in the Department of Advanced Biomedical Sciences, and Associate Professor of Medical Genetics in the Department of Translational Medicine and Department of Pediatrics. Alberto has also been a Lecturer at the European School of Molecular Medicine.

In terms of their research and consulting work, Alberto is the Founder and Consultant of InnovaVector, a company specializing in genetic therapies. Alberto is also the Principal Investigator and Molecular Therapy Program Coordinator at Tigem, a research institute.

Prior to these roles, Alberto served as the General Secretary of the European Society of Gene and Cell Therapy. Alberto had also briefly worked as a Lecturer in Medical Genetics at the University of Naples Federico II.

Alberto Auricchio's work experience demonstrates their expertise in medical genetics, gene therapy, and academic leadership within the field.

Alberto Auricchio's education history began in 1987 when they enrolled in Università degli Studi di Napoli Federico II. Alberto completed their Doctor of Medicine degree (MD) at this institution in 1993, graduating cum laude.

In 1998, Alberto Auricchio pursued further education at the Education Commission for Foreign Medical Graduates, where they obtained their USMLE certification in Medicine.

Later in 1998, they attended Università degli Studi di Milano, where they achieved Pediatric Board Certification with cum laude honors from the III Pediatric Clinic.

From 1998 onwards, Alberto Auricchio joined the University of Pennsylvania and embarked on various postdoctoral research positions. Alberto worked as a Postdoctoral Researcher at the Institute of Human Gene Therapy, and concurrently held joint appointments at the Department of Radiology and the Kirby Center for Molecular Ophthalmology. Their joint appointment at the Department of Radiology ended in 2001, while their joint appointment at the Kirby Center for Molecular Ophthalmology continued until that year as well.

In 2000, Alberto Auricchio became a Research Associate at the Institute for Human Gene Therapy, a position that they continue to hold without a specified end year as of the provided information.